ReviewCurrent treatment options in oncology2018
Surgical Treatment for Extramammary Paget's Disease.
Review in Current treatment options in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Treatment Strategies for Extramammary Paget Disease: A Narrative Review of Current Status and Future Directions.Cancers · 2026Review
- Double Lotus Petal Flaps for Large Perianal Defect Reconstruction After Multistage Extramammary Paget Resection.Plastic and reconstructive surgery. Global open · 2026Article
- Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget's disease with bone marrow involvement: a case report.Frontiers in oncology · 2026Article
- Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.International cancer conference journal · 2026Article
- Extramammary Paget's Disease of the Suprapubic Region in a Male: A Novel Diagnostic Imaging Approach and Literature Review.Journal of clinical medicine · 2025Article
- Mohs Micrographic Surgery: A Narrative Review of Current Practices, Emerging Trends, and Case-Based Insights.Advances in therapy · 2025Review
- [Micrographic controlled surgery in everyday dermatosurgery].Dermatologie (Heidelberg, Germany) · 2023Article
- Extramammary Paget's Disease of the Vulva and Concomitant Premalignant/Malignant Vulvar Lesions: A Potential Challenge in Diagnosis and Treatment.Current oncology (Toronto, Ont.) · 2023Article
- Extramammary Paget's disease: Updates in the workup and management.Asian journal of urology · 2022Review
- [Management of malignant adnexal neoplasms of the skin].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021Article
- Prognostic value of treatment options for extramammary Paget's disease: a SEER database analysis.Translational cancer research · 2021Article
- A primer on extramammary Paget's disease for the urologist.Translational andrology and urology · 2020Review
- Concurrence of Primary Cutaneous Extra Mammary Paget's Disease and Squamous Cell Carcinoma in situ of Vulva: A Case Report.Iranian journal of pathology · 2020Article
- Genitourinary extramammary Paget's disease: review and outcome in a multidisciplinary setting.International journal of clinical and experimental pathology · 2020Article
- High Risk of Proximal and Local Neoplasms in 2206 Patients With Anogenital Extramammary Paget's Disease.Diseases of the colon and rectum · 2019Article
- Paget disease of the vulva an analysis of 24 cases.Medicine · 2019Article
- Use of an Anal Retractor Device for Excision in Patients with Perianal Extramammary Paget's Disease.Indian journal of dermatologyArticle
- Recurrence of Noninvasive Perianal Extramammary Paget's Disease in the Lymph Nodes without Local Recurrence after Complete Excision.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementExtramammary Paget's disease (EMPD) is a rare, slow growing non-melanoma skin cancer.Diagnosis is often significantly delayed, since clinical presentation may resemble common benign dermatoses. Treatment is characterized by high recurrence rates. This is in part due to ill-defined margins and by frequent development of satellites. Improvement of outcome needs a better preoperative planning with fluorescence diagnostics or scouting biopsies. Mohs micrographic surgery has some advantages for patients, such as reduced relapse rates and prolonged relapse-free survival. Improved identification of Paget cells in cryosections by immunostainings or alternatively the use of delayed Mohs with formalin-fixed material reduces the rate of false-negative results. Surgery remains the cornerstone of treatment.
Indexed as
Identifiers
29725859What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.